Company Overview

iAnthus Capital Holdings, Inc. is a U.S.-focused cannabis company engaged in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. The company operates in the regulated cannabis industry through a portfolio of licensed assets and dispensaries across multiple U.S. states. Its primary revenue drivers include cannabis retail sales through dispensaries, branded cannabis products, wholesale distribution, and cultivation operations supporting both internal and third-party demand.

The company historically positioned itself as a multi-state operator (MSO) with vertically integrated operations in several regulated cannabis markets. Its business evolved through acquisitions, licensing arrangements, and expansion into high-growth state cannabis markets following its founding in 2014. Public filings and restructuring disclosures indicate that iAnthus experienced significant financial distress beginning in 2020, leading to recapitalization efforts and operational restructuring aimed at stabilizing liquidity and preserving core assets. The company’s strategic positioning has centered on maintaining exposure to limited-license cannabis jurisdictions with established consumer demand and regulatory barriers to entry.

Business Operations

iAnthus generates revenue primarily through its Retail, Cultivation, and Processing & Manufacturing operations. The company has operated branded dispensaries and production facilities in states including Florida, Massachusetts, New York, New Jersey, Maryland, and Arizona, among others. Its vertically integrated structure allows the company to cultivate cannabis, manufacture derivative products such as concentrates and edibles, and distribute products through owned retail channels. Public disclosures have identified several operating subsidiaries and state-level license holders supporting these activities.

The company has controlled cannabis cultivation assets, dispensary licenses, production infrastructure, and retail brands in regulated U.S. cannabis markets. iAnthus previously expanded through acquisitions including MPX Bioceutical Corporation, which materially increased its operational footprint. The company has also maintained partnerships and licensing relationships associated with state-regulated cannabis operations. Following financial restructuring initiatives, management has focused on rationalizing assets, improving operating efficiency, and prioritizing markets with stronger profitability potential.

Strategic Position & Investments

iAnthus has pursued a strategy focused on participation in limited-license cannabis states where regulatory frameworks can constrain competition and support pricing stability. Growth initiatives historically included dispensary expansion, cultivation capacity increases, product brand development, and acquisitions designed to broaden geographic reach. The acquisition of MPX Bioceutical Corporation represented one of the company’s most significant strategic transactions, substantially expanding its U.S. operational presence and cultivation capabilities.

The company’s more recent strategic direction has emphasized financial restructuring, operational streamlining, and capital preservation. Public filings and restructuring disclosures indicate efforts to reduce debt obligations, optimize underperforming assets, and focus on markets with scalable retail and cultivation economics. iAnthus has also maintained exposure to emerging cannabis product categories including concentrates, vapes, edibles, and wellness-oriented cannabis products, although expansion activity has been more measured following its recapitalization process. Certain operational and investment details remain subject to evolving state regulations and ongoing financial disclosures.

Geographic Footprint

iAnthus is headquartered in New York, United States, and its operations have primarily focused on the U.S. cannabis market. The company has maintained operational exposure across several states through cultivation facilities, processing centers, and retail dispensaries. Historically significant markets have included Florida, Massachusetts, New York, Maryland, New Jersey, and Arizona, reflecting a strategy centered on populous states with medical or adult-use cannabis programs.

The company’s market presence has largely been concentrated in North America, specifically within regulated U.S. jurisdictions where cannabis operations are permitted under state law. While publicly traded in Canada and accessible to international investors through over-the-counter markets in the United States, its operating assets and commercial activities have remained U.S.-focused. Regulatory variation across states materially influences operational strategy, licensing opportunities, and market expansion decisions.

Leadership & Governance

iAnthus was co-founded by Hadley Ford and Randy Maslow, who were involved in establishing the company’s early multi-state cannabis strategy. Leadership changes occurred following the company’s financial restructuring and recapitalization initiatives. Governance and executive oversight have focused on liquidity management, operational stabilization, and restructuring execution in response to industry-wide capital market pressures and company-specific debt obligations.

Key executives and leadership figures identified in public filings and company disclosures include:

• Hadley Ford – Co-Founder and former Chief Executive Officer
• Randy Maslow – Co-Founder and former executive leadership figure
• Robert Galvin – Former Interim Chief Executive Officer
• Julius Kalcevich – Chief Financial Officer (historically referenced in company disclosures)
• Dennis Curran – Executive Chairman (historically referenced during restructuring period)

The company’s leadership philosophy has emphasized disciplined capital allocation, regulatory compliance, and operational efficiency within the evolving U.S. cannabis industry. Some executive roles and governance positions have changed over time due to restructuring activity and board transitions. Data regarding certain current executive appointments is inconclusive based on available public sources.